IXHL News and Press, Incannex Healthcare Limited From 06/03/22

Incannex announces positive results from phase 2 clinical trial investigating the effect of IHL-42X for treatment of obstructive sleep apnoea PR Newswire Highlights: IHL-42X reduced primary endpoint apnoea hypopnea index relative to baseline at all three doses ...

Incannex Announces Positive Pre-IND Meeting with U.S. FDA for IHL-42X for Obstructive Sleep Apnoea PR Newswire MELBOURNE, Australia , May 17, 2022 /PRNewswire/ -- Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a clini...

Incannex Completes Share Sale and Purchase Agreement to Wholly Acquire APIRx Pharmaceuticals USA, LLC PR Newswire MELBOURNE, Australia , May 12, 2022 /PRNewswire/ -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a cl...

Incannex announces IHL-216A observed to have a neuroprotective effect in a rodent model of sports concussion; rapidly restores spatial memory post-concussion PR Newswire Highlights: The study compared IHL-216A to its component drugs, cannabidiol (CBD) and isofl...

Quarterly Activities Report and Appendix 4C Cash Flow Statement PR Newswire Highlights: Positive phase 2a clinical trial results for IHL-42X with 60% of trial participants experiencing at least a 55% reduction in the Apnoea Hypopnea Index ('AHI') 20% of IHL...

Incannex Completes Loyalty Option Program to Raise A$23.6M; Current Cash at Bank is Approximately A$40.0M PR Newswire MELBOURNE, Australia , April 28, 2022 /PRNewswire/ -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), ('Incannex' or the 'Company'...

Gainers: Enphase Energy (ENPH) +5%. eXp World Holdings  (EXPI) +5%. Lucid Group (LCID) +5%. Anavex Life Sciences  (AVXL) +5%. Wejo Group Limited (WEJO) +5%. Losers: Incannex Healthcare  (IXHL) -14%. Sono Group  (SEV) -12%. F5 (FFIV) -11%. Alph...

Incannex Healthcare (NASDAQ:IXHL), a clinical-stage pharmaceutical company focused on cannabinoid and psychedelic medicines, announced an agreement to acquire the U.S.-based biotech APIRx Pharmaceutical. The ADRs of Australia-based Incannex (IXHL) are trading ~8% higher in the pre-m...

Mercurity Fintech Holding (MFH) +65%. Fast Radius (FSRD) +21%. Nikola (NKLA) +18% after investor event. Femasys (FEMY) +13%. BiondVax Pharmaceuticals (BVXV) +13% on research pact to develop nanosized antibody therapies. Incannex Healthcare (IXHL) +12%. D-MARKET Elektronik&...

Incannex to Acquire APIRx Pharmaceuticals USA, LLC PR Newswire Highlights: APIRx has twenty-two (22) active clinical and pre-clinical research and development projects therapeutic candidates are targeted at treating pain, dementia, Parkinson's disease, rest...